Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-17
    E.g., 2018-10-17

Articles

Pages

12347 items
1:55 PM, Oct 16, 2018  |  BC Extra | Financial News

Taiho Ventures ups investments to $300M, to focus on oncology

Taiho Ventures LLC increased its investment pool to $300 million from $50 million. Taiho Ventures said it will focus the additional funds on oncology startups with drug discovery capabilities or unique platform technologies. Taiho Pharmaceutical Co....
3:26 PM, Oct 12, 2018  |  BC Extra | Financial News

Biotech stocks ride tech rally

Biotech indexes ended the week on a positive note but it wasn’t enough to salvage the week. The NASDAQ Biotechnology Index (NBI), SPDR S&P Biotech ETF (XBI), BioCentury 100 and NYSE Arca Biotechnology Index (BTK) each...
1:47 PM, Oct 12, 2018  |  BC Extra | Financial News

Iovance raises $219M for Phase II trials

Iovance Biotherapeutics (NASDAQ:IOVA) raised $219.3 million in a follow-on Friday to fund five ongoing company-sponsored Phase II trials of its tumor infiltrating lymphocyte (TIL) cell therapies and prepare for potential launch of its lead TIL...
10:03 PM, Oct 10, 2018  |  BC Extra | Financial News

Gene therapy company Audentes raises $151M

On the heels of data for one of its gene therapies, Audentes Therapeutics Inc. (NASDAQ:BOLD) raised $150.8 million Wednesday through the sale of 5.2 million shares at $29 in a follow-on underwritten by BofA Merrill...
7:40 PM, Oct 10, 2018  |  BC Extra | Financial News

First-day pop for Allogene after year's largest biotech IPO on NASDAQ

Less than a year after it was founded, cell therapy company Allogene Therapeutics Inc. (NASDAQ:ALLO) raised $324 million late Wednesday in the largest IPO by a biotech on NASDAQ thus far in 2018. The company...
4:40 PM, Oct 10, 2018  |  BC Extra | Financial News

Biotech slides with broader market

Biotech indexes fell Wednesday, mostly in line with the broader markets, marking significant mid-week losses. The moves come among continued trade tensions with China and follows the Federal Reserve raising interest rates for the third...
9:01 PM, Oct 09, 2018  |  BC Extra | Financial News

Versant-backed Gotham raises $54M series A

Versant Ventures unveiled a move into the RNA metabolism space with an investment in Gotham Therapeutics (New York, N.Y.). Versant co-led a $54 million series A round with Forbion Capital Partners and SR One. Gotham is...
1:10 PM, Oct 09, 2018  |  BC Extra | Financial News

Polaris, Arch co-lead series A for MIT spinout Glympse

With $22 million in new series A funding, Glympse Bio Inc. (Cambridge, Mass.) plans to start clinical testing by mid-2019 of its bio-engineered diagnostic for non-alcoholic steatohepatitis (NASH). Glympse is developing injectable bio-engineered activity sensors...
2:37 PM, Oct 08, 2018  |  BC Extra | Financial News

Immunometabolism company Sitryx debuts with GSK ties, $30M

Sitryx Therapeutics Ltd. (Oxford, U.K.) emerged from stealth on Monday with $30 million from a series A round to develop disease-modifying therapeutics for immuno-oncology and immuno-inflammation, which CEO Neil Weir expects to be enough runway...
1:40 PM, Oct 08, 2018  |  BC Extra | Financial News

5AM looking for $350M sixth fund

5AM Ventures aims to raise $350 million for its sixth fund, according to an SEC filing. The firm raised $285 million for its fifth fund, which closed in May 2016. 5AM led or co-led recent investments...

Pages